Fredun [FREDUN] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Fredun Pharmaceuticals Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fredun Pharmaceuticals Ltd. wins in 12 metrics, Innova Captab Ltd. wins in 8 metrics, with 0 ties. Fredun Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fredun Pharmaceuticals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 29.83 31.20 Fredun Pharmaceuticals Ltd.
Price-to-Book Ratio 6.26 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio 108.78 32.95 Innova Captab Ltd.
PEG Ratio 0.31 1.33 Fredun Pharmaceuticals Ltd.
EV/EBITDA 13.98 20.49 Fredun Pharmaceuticals Ltd.
Profit Margin (TTM) 5.53% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 15.26% 12.88% Fredun Pharmaceuticals Ltd.
EBITDA Margin (TTM) 15.26% 12.88% Fredun Pharmaceuticals Ltd.
Return on Equity 13.96% 13.37% Fredun Pharmaceuticals Ltd.
Return on Assets (TTM) 4.05% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-351.69M $-1.09B Fredun Pharmaceuticals Ltd.
Dividend Yield 0.09% 0.30% Innova Captab Ltd.
1-Year Return 183.86% 3.87% Fredun Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 1.93 2.76 Fredun Pharmaceuticals Ltd.
Enterprise Value $11.27B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.91 2.90 Fredun Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 28.72% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $1,273 $262 Fredun Pharmaceuticals Ltd.
Earnings per Share (Diluted) $69.90 $23.16 Fredun Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.46 -0.33 Innova Captab Ltd.

Fredun Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

FREDUN
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fredun Pharmaceuticals Ltd.0.17%0.73%-2.19%43.43%39.40%50.67%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fredun Pharmaceuticals Ltd.183.86%158.56%447.18%11,453.75%18,386.00%18,386.00%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Fredun Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricFREDUNINNOVACAP
Market Information
Market Cap i₹11.55B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,259578,151
90 Day Avg. Volume i9,301217,693
Last Close₹2,314.65₹947.95
52 Week Range₹791.00 - ₹2,620.00₹622.00 - ₹978.00
% from 52W High-11.65%-3.07%
All-Time High₹2,620.00 (May 25, 2026)₹1,260.00 (Jan 06, 2025)
% from All-Time High-11.65%-24.77%
Growth Metrics
Quarterly Revenue Growth0.57%0.42%
Quarterly Earnings Growth0.97%0.23%
Financial Health
Profit Margin (TTM) i0.06%0.09%
Operating Margin (TTM) i0.15%0.13%
Return on Equity (TTM) i0.14%0.13%
Debt to Equity (MRQ) i108.7832.95
Cash & Liquidity
Book Value per Share (MRQ)₹333.11₹178.28
Cash per Share (MRQ)₹18.49₹10.22
Operating Cash Flow (TTM) i₹-1,140,997,000₹282.88M
Levered Free Cash Flow (TTM) i₹197.39M₹1.28B
Dividends
Last 12-Month Dividend Yield i0.09%0.30%
Last 12-Month Dividend i₹0.70₹2.00

Valuation & Enterprise Metrics Analysis: Fredun Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricFREDUN (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i29.8331.20
Forward P/E iN/A21.90
PEG Ratio i0.311.33
Price to Sales (TTM) i1.932.76
Price to Book (MRQ) i6.264.05
Market Capitalization
Market Capitalization i₹11.55B₹41.43B
Enterprise Value i₹11.27B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.912.90
Enterprise to EBITDA i13.9820.49
Risk & Other Metrics
Beta i0.46-0.33
Book Value per Share (MRQ) i₹333.11₹178.28

Financial Statements Comparison: Fredun Pharmaceuticals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFREDUN (2025)INNOVACAP (2025)
Revenue/Sales i4.52B12.34B
Cost of Goods Sold i3.45B8.38B
COGS % of Revenue i76.5%67.9%
Gross Profit i1.06B3.96B
Gross Margin i23.5%32.1%
Research & Development i49.76MN/A
Operating Income (EBIT) i475.31M1.65B
Operating Margin i10.5%13.4%
EBITDA i530.69M2.00B
EBITDA Margin i11.7%16.2%
Pre-Tax Income i274.94M1.71B
Pre-Tax Income % of Revenue i6.1%13.9%
Income Tax i77.54M427.58M
Income Tax % of Revenue i1.7%3.5%
Net Income (Profit) i197.39M1.28B
Profit Margin i4.4%10.4%

Balance Sheet & Liquidity Metrics

MetricFREDUN (2025)INNOVACAP (2025)
Cash & Equivalents i6.37M155.19M
Total Current Assets i4.28B7.03B
Total Current Assets % of Revenue i94.7%57.0%
Total Current Liabilities i3.28B3.53B
Total Current Liabilities % of Revenue i72.6%28.6%
Long-Term Debt i96.13M2.45B
Long-Term Debt % of Revenue i2.1%19.8%
Total Shareholders Equity i1.41B9.59B
Retained Earnings i628.39M4.53B
Retained Earnings % of Revenue i13.9%36.7%
Property, Plant & Equipment i95.24M442.93M

Cash Flow Statement Comparison

MetricFREDUN (2025)INNOVACAP (2025)
Operating Cash Flow i-1.14B282.88M
Operating Cash Flow % of Revenue i-25.3%2.3%
Capital Expenditures i-59.94M-1.72B
Free Cash Flow i-351.69M-1.09B
FCF Margin i-7.8%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFREDUNINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i5.47M57.22M
Float Shares i534,24115.91M
% Held by Insiders i53.36%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i46.64%8.59%

Dividend Analysis & Yield Comparison: Fredun Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricFREDUNINNOVACAP
Last 12-Month Dividend i₹0.70₹2.00
Last 12-Month Dividend Yield i0.09%0.30%
3-Year Avg Annual Dividend i₹0.70₹0.67
3-Year Avg Dividend Yield i0.08%0.30%
3-Year Total Dividends i₹2.10₹2.00
Ex-Dividend DateSep 23, 2024Jan 30, 2026